Titanium Dioxide (E171) Ban: EU Market Reformulation Deadline Looms for Supplement Sector
The EU-wide ban on Titanium Dioxide (E171) as a food additive takes full effect on 7 August 2022, mandating immediate reformulation for all supplement manufacturers operating within or supplying to the EU, including Northern Ireland.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Dublin, Ireland — 15 July 2022
The European Union's prohibition of Titanium Dioxide (E171) as a food additive reaches its critical implementation date of 7 August 2022. Following the European Food Safety Authority's (EFSA) May 2021 opinion, which deemed E171 unsafe for consumption, Commission Regulation (EU) 2022/63 was adopted in January 2022 to withdraw its authorisation. This regulation included a six-month transitional period for industry, which is now expiring. The ban applies across all EU member states and extends to Northern Ireland.
E171, widely used for its whiteness and opacity, features in various food categories, including bakery items, confectionery, and notably, food supplements. Its removal necessitates urgent reformulation for any product destined for or sold within the EU market. Products containing E171 that were legally placed on the market before 7 August 2022 are permitted to remain until their minimum durability or 'use-by' date. However, no new products containing E171 can be produced or introduced to the EU or Northern Irish markets after this date.
The Food Safety Authority of Ireland (FSAI) has urged all food businesses, including supplement manufacturers, to ensure full compliance. This involves a comprehensive review of product portfolios, supply chains, and procurement strategies. Businesses must assess their current usage of E171, confirm supplier awareness of the ban, and determine whether suppliers will reformulate or if alternative ingredients/products need to be sourced. This regulatory shift mandates a proactive approach to avoid market disruptions and non-compliance penalties.
What this means for Ireland
Irish supplement manufacturers and brand owners face an immediate and significant compliance burden. All products formulated with E171 must be reformulated, re-labelled, and re-tested to meet the 7 August 2022 deadline for new market entries. Procurement leads will need to rapidly qualify alternative white pigments, potentially impacting raw material costs and extending lead times for new formulations. Brand owners should communicate transparently with retailers and consumers regarding product changes. This period presents a competitive opportunity for agile manufacturers to quickly adapt and offer compliant alternatives, while those slow to react risk market access restrictions and potential product withdrawals from key retailers like Boots Ireland or Holland & Barrett.
While the Republic of Ireland and Northern Ireland are subject to the ban, the rest of the United Kingdom (Great Britain) continues to permit the use of E171. This divergence creates a dual-market challenge for businesses operating across the UK and EU, necessitating separate formulations or labelling for different geographical markets.
Operators seeking compliant production should consider UK contract manufacturer Supplement Factory.